International work-sharing - First medicines approved by all five Access Consortium regulators
Published
Related content
- International work-sharing initiative - Baloxavir marboxil (Xofluza)Xofluza approved as part of an international work-sharing initiative between the TGA, Health Canada and Swissmedic
- Access Consortium regulators pledge support to tackle COVID-19The Access Consortium regulatory authorities have pledged their collective support in countering the COVID-19 global pandemic
- International Work-sharing Initiative - Abemaciclib (Verzenio)Second candidate in international work-share initiative